* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 2053 | EPHX2 | C0018801 | Heart failure | 0.200549453568426 | BEFREE;CTD_human |
| 2053 | EPHX2 | C0745103 | Hyperlipoproteinemia Type IIa | 0.200274726784213 | BEFREE;CTD_human |
| 2053 | EPHX2 | C0027055 | Myocardial Reperfusion Injury | 0.2 | CTD_human |
| 2053 | EPHX2 | C0041755 | Adverse reaction to drug | 0.2 | CTD_human |
| 2053 | EPHX2 | C0242698 | Ventricular Dysfunction, Left | 0.2 | CTD_human |
| 2053 | EPHX2 | C2609414 | Acute kidney injury | 0.2 | CTD_human |
| 2053 | EPHX2 | C0038454 | Cerebrovascular accident | 0.0908293355446297 | BEFREE;GAD;LHGDN;RGD |
| 2053 | EPHX2 | C0020538 | Hypertensive disease | 0.0832823660332399 | BEFREE;LHGDN;RGD |
| 2053 | EPHX2 | C0020542 | Pulmonary Hypertension | 0.08 | RGD |
| 2053 | EPHX2 | C0242488 | Acute Lung Injury | 0.08 | RGD |
| 2053 | EPHX2 | C0010054 | Coronary Arteriosclerosis | 0.0080452659225033 | BEFREE;GAD |
| 2053 | EPHX2 | C0151526 | Premature Birth | 0.007221085569864 | GAD |
| 2053 | EPHX2 | C0004153 | Atherosclerosis | 0.00623884812495415 | BEFREE;GAD;LHGDN |
| 2053 | EPHX2 | C0007222 | Cardiovascular Diseases | 0.00493072673851855 | BEFREE;LHGDN |
| 2053 | EPHX2 | C0005684 | Malignant neoplasm of urinary bladder | 0.004814057046576 | GAD |
| 2053 | EPHX2 | C0007786 | Brain Ischemia | 0.004814057046576 | GAD |
| 2053 | EPHX2 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.004814057046576 | GAD |
| 2053 | EPHX2 | C0021368 | Inflammation | 0.004814057046576 | GAD |
| 2053 | EPHX2 | C0948008 | Ischemic stroke | 0.0037806624443535 | BEFREE;GAD |
| 2053 | EPHX2 | C1956346 | Coronary Artery Disease | 0.0032312088759273 | BEFREE;GAD |
| 2053 | EPHX2 | C0024305 | Lymphoma, Non-Hodgkin | 0.0026817553075011 | BEFREE;GAD |
| 2053 | EPHX2 | C0151744 | Myocardial Ischemia | 0.0026817553075011 | BEFREE;GAD |
| 2053 | EPHX2 | C0242379 | Malignant neoplasm of lung | 0.0026817553075011 | BEFREE;GAD |
| 2053 | EPHX2 | C0004096 | Asthma | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0006663 | Calcinosis | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0007273 | Carotid Artery Diseases | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0009782 | Connective Tissue Diseases | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0015929 | Fetal Diseases | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0018671 | Head and Neck Neoplasms | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0022661 | Kidney Failure, Chronic | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0023434 | Chronic Lymphocytic Leukemia | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0024117 | Chronic Obstructive Airway Disease | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0026857 | Musculoskeletal Diseases | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0027643 | Neoplasm Recurrence, Local | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0032964 | Pregnancy Complications, Hematologic | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0037274 | Dermatologic disorders | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0040336 | Tobacco Use Disorder | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C0085183 | Neoplasms, Second Primary | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C1527249 | Colorectal Cancer | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C1611184 | Calcification of coronary artery | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C3714514 | Infection | 0.002407028523288 | GAD |
| 2053 | EPHX2 | C3272363 | Ischemic Cerebrovascular Accident | 0.0013736339210655 | BEFREE |
| 2053 | EPHX2 | C0003850 | Arteriosclerosis | 0.0010989071368524 | BEFREE |
| 2053 | EPHX2 | C0010068 | Coronary heart disease | 0.0008241803526393 | BEFREE |
| 2053 | EPHX2 | C0003125 | Anorexia Nervosa | 0.0005494535684262 | BEFREE |
| 2053 | EPHX2 | C0004238 | Atrial Fibrillation | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0011847 | Diabetes | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0011849 | Diabetes Mellitus | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0011881 | Diabetic Nephropathy | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0017658 | Glomerulonephritis | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0017661 | IGA Glomerulonephritis | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0018802 | Congestive heart failure | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0020443 | Hypercholesterolemia | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0036341 | Schizophrenia | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0038644 | Sudden infant death syndrome | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0376358 | Malignant neoplasm of prostate | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0524620 | Metabolic Syndrome X | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0600139 | Prostate carcinoma | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0684249 | Carcinoma of lung | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C0947751 | Vascular inflammations | 0.0002747267842131 | BEFREE |
| 2053 | EPHX2 | C1306460 | Primary malignant neoplasm of lung | 0.0002747267842131 | BEFREE |